Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Cisplatin and Mitomycin-C for Unresectable Hepatocellular Carcinoma
NCT00183885Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Oct 2004
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, mitomycin c in hepatocellular carcinoma (HCC), sponsored by University of Southern California. Started Oct 2004; status: completed.
02
Drugs
cisplatinmitomycin c
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00183885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183885.